NCT04317040 · Interventional trial
Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)
Overall registry status Completed
Phase 3
Conditions Coronavirus Disease 2019 (COVID-19)
Delaware Valley sites
- Cooper University Hospital · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory